Chronic Constipation
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Chronic constipation is a moderately active landscape with 33 programs across 17 companies. The most active players are Motus Therapeutics, Inc., Ironwood Pharmaceuticals, Inc., Kissei Pharmaceutical Co., Ltd.. 8 therapies are approved with 10 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Analysis
Modality Breakdown
97%
Small molecule
38 of 39 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 39 classified programs, each share of the total. Modality classified for 100% of 41 pipeline programs.
Analysis
Trial Status
73
clinical trials
Clinical Trials
Trial Activity
73 trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.·Phase 3·NCT01116206·507 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)